LAMEA Protein Chip Market By End User (Pharmaceuticals and Biotechnology Sector, Academic & Research Institutes, Diagnostic Laboratories and Hospitals and Clinics), By Technology (Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics and Antibody Characterization), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Market Report Description

The Latin America, Middle East and Africa Protein Chip Market would witness market growth of 10.19% CAGR during the forecast period (2021-2027).

The growth of the Protein Chip Market is attributed to the determinants like the increasing rate of cancer cases, growing technological advancements in diagnostic tests, and increasing awareness about customized medicines among the population. Along with that, the rise in government initiatives and huge investments in R&D of different Protein Chip Market methods are estimated to fuel the growth of the Protein Chip Market during the forecast period. Protein Chip Markets are also utilized to study the fundamental biology of various organisms on the basis of gene expression.

Protein Chip Markets are used across various research laboratories of different domains to track protein activities and functionalities. Due to this, the demand for these Protein Chip Markets would surge across this region in the forecast period. As the healthcare system of developing nations of the region is becoming stronger, the demand for Protein Chip Markets would boost in the coming years.

The Brazil market dominated the LAMEA Protein Chip Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $20.1 million by 2027. The Argentina market is experiencing a CAGR of 10.8% during (2021 - 2027). Additionally, The UAE market would showcase CAGR of 9.6% during (2021 - 2027).

Based on End User, the market is segmented into Pharmaceuticals and Biotechnology Sector, Academic & Research Institutes, Diagnostic Laboratories and Hospitals and Clinics. Based on Technology, the market is segmented into Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. Based on Application, the market is segmented into Diagnostics, Proteomics and Antibody Characterization. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Protein Chip Market is Predict to reach $1,292.5 Million by 2027, at a CAGR of 9.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., RayBiotech Life, Inc., Quotient limited, Danaher Corporation, Arrayit Corporation, Merck Group, and Illumina, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User

• Pharmaceuticals and Biotechnology Sector
• Academic & Research Institutes
• Diagnostic Laboratories and
• Hospitals and Clinics

By Technology

• Analytical Microarrays
• Functional Protein Microarrays and
• Reverse Phase Protein Microarrays

By Application

• Diagnostics
• Proteomics and
• Antibody Characterization

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• RayBiotech Life, Inc.
• Quotient limited
• Danaher Corporation
• Arrayit Corporation
• Merck Group
• Illumina, Inc.